Managing Patients With Neurotrophic Keratitis (NK)
* Team-based care * Treatment * General care * Prevention * Symptomatic treatment * Cenegermin * Safety, efficacy, role in treatment/patient selection * Cost * Storage and administration * Corneal neurotization * Investigational therapies Key Concepts: * Most patients should receive basic preventive and symptomatic care, as well as active treatment in certain cases * Cenegermin promotes corneal healing and is the only medication approved for the treatment of patients with neurotrophic keratitis
4 jaksot
Kommentit
0Ole ensimmäinen kommentoija
Rekisteröidy nyt ja liity Managing Patients With Neurotrophic Keratitis (NK)-yhteisöön!